What is GHRP-2?
GHRP-2 is a growth-hormone-releasing peptide and a strong stimulator of growth-hormone release. It is not FDA-approved and falls within the peptides under the 2026 compounding review.
How it is thought to work
GHRP-2 acts on the ghrelin receptor to prompt growth-hormone release. It is considered more potent than some related peptides, which a provider balances against individual tolerance and goals.
What the research shows
Studies have examined its effect on growth-hormone levels. As with related peptides, large long-term human outcome data is limited.
We summarize published research and do not make therapeutic promises. A licensed provider can evaluate whether any therapy is appropriate for you. Treat any source promising guaranteed results with skepticism.
Studied uses
- Growth-hormone release support
- Body-composition protocols
- Recovery support
Legal status in 2026
GHRP-2 is not FDA-approved and is among the peptides under federal review in 2026. No rule has changed yet, and it would remain prescription-only even if reclassified.
How to access GHRP-2 legitimately
A licensed provider evaluates candidacy and, where permitted, prescribes through a licensed compounding pharmacy with monitoring.
PeptideForward can match you with vetted telehealth providers who handle these therapies through legitimate channels. The eligibility check takes about five minutes and there is no cost to see if you are a candidate.
Frequently asked questions
How is GHRP-2 different from GHRP-6? Both are growth-hormone-releasing peptides. GHRP-2 is often described as more potent, while GHRP-6 is noted for stronger appetite effects. A provider can explain the practical differences.
Is it legal now? It is not approved. Where permitted it requires a prescription, and its compounding status is under 2026 review.
Does PeptideForward sell it? No. We connect you with licensed providers only.